Approved Study Database
Ref. No. | Scientific Title | Principal investigator |
---|---|---|
2010.138 | A Phase III, Randomized, Clinical Trial to Evaluate the Safety and Efficacy of the Addition of Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on a Sulfonylurea in Combination With Metformin | Dr. Ozaki Risa |
2013.490 | A Prospective, Randomized, Open-Label Comparison of a Long-Acting Basal Insulin Analog, LY2963016, to Lantus® in Combination with Mealtime Insulin Lispro in Adult Patients with Type 1 Diabetes Mellitus: The ELEMENT 3 Study | Dr. Ozaki Risa |
2011.029 | A Randomized, Double-Blind, Placebo-controlled, 3-Arm, Parallel-Group, 26-Week, Multicenter Study With a 26-Week Extension, to Evaluate the Efficacy, Safety and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus Who Have Moderate Renal Impairment | Dr. Ozaki Risa |
2011.152 | A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment with Exenatide Once Weekly in Patients with Type 2 Diabetes Mellitus | Dr. OZAKI Risa |
2011.080 | A Phase III, Multicenter, Randomized, Open-label Clinical Trial Comparing the Efficacy and Safety of a Sitagliptin-Based Treatment Paradigm to a Liraglutide-Based Treatment Paradigm in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin Monotherapy | Dr Ozaki Risa |
2013.293 | A randomized, double-blind, placebo-controlled, multi-center study to assess the safety and efficacy of different oral doses of BAY 94-8862 in subjects with type 2 diabetes mellitus and the clinical diagnosis of diabetic nephropathy | Dr. OZAKI Risa |
2009.428 | Dose Finding, Safety and Efficacy of Monthly Subcutaneous Canakinumab Administration for the Treatment of Hyperglycemia in Metformin Monotherapy Treated Type 2 Diabetic Patients: a Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study | Dr Ozaki Risa |
2008.321 | Superiority Study of Insulin Glargine Over Sitagliptin in Insulin-Na_ve Patients with Type 2 Diabetes Treated With Metformin and Not Adequately Controlled (EASIE Trial | Dr Ozaki Risa |
2008.322 | Combination Therapy of Insulin Glargine and Sitagliptin in Patients with Type 2 Diabetes Not Adequately Controlled by A Previous Treatment with Metformin and Either Insulin Glargine or Sitagliptin (EASIE Extension trial | Dr Ozaki Risa |
2013.531 | A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP, MULTI-CENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ONCE-DAILY ADMINISTRATION OF A CHEMOKINE CCR2/5 RECEPTOR ANTAGONIST (PF-04634817) IN ADULTS WITH TYPE 2 DIABETES AND OVERT NEPHROPATHY | Dr Ozaki Risa |
2013.098 | A Multicenter Open-label Extension (OLE) Study to Assess the Long-term Safety and Efficacy of AMG 145 | Dr Ozaki Risa |
2014.136 | Verifying Insulin Strategy and Initial Health Outcome Analysis (VISION) | Dr. OZAKI Risa |
2013.152 | A randomized controlled trial of a tailored intervention targeted smoking type 2 diabetic patients to promote smoking cessation and improve glycamic control | Dr. Ozaki Risa |
2011.604 | A 5-year study to compare the durability of glycemic control of a combination regimen with vildagliptin & metformin versus standard-of-care monotherapy with metformin, initiated in treatment-naïve patients with type 2 diabetes mellitus | Dr. OZAKI Risa |
2008.041 | A Phase II, Double-blind, Placebo-controlled, Dose-finding Study in Patients with Diabetic Neuropathic Pain to Evaluate Efficacy and Safety of TAK-583 | Dr Ozaki Risa |
2012.273 | A Double-blind, Randomized, Placebo and Ezetimibe Controlled, Multicenter Study to Evaluate Safety, Tolerability and Efficacy of AMG 145 on LDL-C in Combination With Statin Therapy in Subjects With Primary Hypercholesterolemia and Mixed Dyslipidemia | Dr Ozaki Risa |
2012.108 | A Phase III, multicentre, international, randomised, parallel group, double blind cardiovascular safety study of BI 10773 (10 mg and 25 mg administered orally once daily) compared to usual care in type 2 diabetes mellitus patients with increased cardiovascular risk | Dr. OZAKI Risa |
2024.477 | Clinical Characteristics of Patient with Tumour Induced Osteomalacia in Hong Kong | Dr. OZAKI Risa |
2015.095 | A long term, randomised, double blind, placebo-controlled study to determine the effect of albiglutide, when added to standard blood glucose lowering therapies, on major cardiovascular events in patients with Type 2 diabetes mellitus Harmony Outcomes Trial | Dr. OZAKI Risa |
2014.450 | A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin® (pyridoxamine dihydrochloride) in Subjects with Nephropathy Due to Type 2 Diabetes (PIONEER) | Dr. OZAKI Risa |
2015.195 | Insulin, Glucagon and Incretin Response to 75g Glucose Tolerance Tests: Comparison of Type 2 diabetes and healthy control among Asian Countries |
Dr. OZAKI Risa 尾崎麗莎 |
2015.351 | An open-label, randomized, multi-center, single dose, two-period, two-sequence crossover study to investigate the bioequivalence of Peginterferon (PEG-IFN) alfa-2a benzyl alcohol-free formulation versus the reference market formulation following subcutaneous administration via prefilled syringe in healthy Chinese subjects |
Dr. OZAKI Risa Not applicable |
2014.425 | A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects with Type 2 Diabetes and Nephropathy - SONAR: Study Of Diabetic Nephropathy with Atrasentan | Dr. OZAKI Risa |
2014.366 | A Randomized, Double-blind, Event-driven, Placebo-controlled, Multicenter Study of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Subjects With Type 2 Diabetes Mellitus and Diabetic Nephropathy | Dr OZAKI Risa |
2010.588 | The correlation between increased arterial stiffness and the 5-year probability of major clinical event generated from the risk engine JADE program | Dr. Ozaki Risa |
2010.245 | Comparison of mearsuring subglottic airway diameter between 4D USG and standard MRI imaging in healthy adult volunteers | Dr Or Yin Ling |
2015.476 | Hope in the Context of Chronic Musculoskeletal Pain: Relationships of Hope to Pain and Psychological Distress |
Dr. OR Yin Ling 柯燕玲 |
2005.446 | 針刺曲池穴的即時降壓療效之臨床觀察 | OR Wai Leung William |
2007.464 | A Questionnaire Survey on Emergency Nurses' Competency after the Application of Mental Health Triage Tool | Ms OR Lai Chun Ikea |
2014.185 | Validation of ischemic stroke traditional Chinese medicine syndrome factor diagnostic scale (ISTCMDS) in Hong Kong | Dr. OR Kevin Ka Hang |
2017.523 | Validation of a clinical diagnostic instrument based on stroke patient records of Chinese medicine masters |
Dr. OR Kevin Ka Hang 柯加恆 |
2015.086 | Bioimpedance spectroscopic detection of altered fluid status among elderly sub-acute congestive heart failure patients: an observational cohort study | Dr. OR Kevin Ka Hang |
2012.457 | A descriptive cohort study of stroke patients from sub-acute to chronic phase based on Ischemic Stroke TCM Syndrome Factor Diagnostic Scale | Dr. OR Kevin Ka Hang |
2021.322 | Effect of Transcranial Direct Current Stimulation (tDCS) on Improving Inhibitory Control and Working Memory in Children with Attention-Deficit / Hyperactivity Disorder (ADHD) and comorbid Autism Spectrum Disorder (ASD) – A Randomised Controlled Trial |
Dr. OR Brian Parr Ning 柯栢菱 |
2021.332 | A Double-Blinded, Randomized-Controlled-Trial to Investigate the Effect of Pulsed Electromagnetic Field (PEMF) for patients with quadriceps weakness after Anterior Cruciate Ligament Reconstruction (ACLR) |
Prof. ONG Tim Yun 王添欣 |
2021.328 | A Double-Blinded, Randomized-Controlled-Trial to Investigate the Effect of Pulsed Electromagnetic Field (PEMF) on Prehabilitation for Patients receiving Anterior Cruciate Ligament Reconstruction |
Prof. ONG Tim Yun 王添欣 |
2021.588 | Patients Undergo Bilateral Quadriceps Inhibition and Weakness After ACL Ruptures |
Prof. ONG Tim Yun 王添欣 |
2021.491 | A Double-Blinded, Randomized-Control-Trial to Investigate the Effect of Pulsed Electromagnetic Field (PEMF) for Patients with Knee Osteoarthritis |
Prof. ONG Tim Yun 王添欣 |
2019.488 | The effect of whole body vibration therapy on increasing quadriceps strength prior to anterior cruciate ligament reconstruction |
Prof. ONG Tim Yun 王添欣 |
2024.107 | The effect of Short Message Service interventions on promoting exercise adherence for patients with knee conditions |
Prof. ONG Michael Tim-Yun Michael Tim-Yun ONG |
2022.185 | A double-blinded, randomised controlled trial to investigate the treatment effects of pulsed electromagnetic field (PEMF) on end stage of Knee Osteoarthritis |
Prof. ONG Michael Tim Yun 王添欣 |
2023.226 | Differences in the gait biomechanics between healthy controls and patients with various stages of hip osteoarthritis | Dr. ONG Michael Tim Yun |
2023.210 | The effectiveness of pulsed electromagnetic field therapy on muscle strength and function in end-stage knee osteoarthritis patients: a randomized controlled trial |
Prof. ONG Michael Tim Yun 王添欣 |
2023.211 | Augmentation of Rotator Cuff Repair with Biodegradable Magnesium Pin: from Bench Side to Bedside | Dr. ONG Michael Tim Yun |
2022.674 | The Effect of Pulsed Electromagnetic Field (PEMF) on Muscle Strength for Elderlies with Knee Pain in Community Center |
Prof. ONG Michael Tim Yun 王添欣 |
2023.291 | A multiphase optimisation strategy to develop an evidence-based adaptive intervention to maximise adherence with the CUHKs Healthy Knees program |
Prof. ONG Michael Tim Yun Michael Tim-Yun Ong |
2021.654 | The Clinical Translation of a Biodegradable Pure Magnesium wire developed for augmentation of ACL reconstruction, from Benchside to Bedside |
Prof. ONG Michael Tim Yun 王添欣 |
2023.208 | Routine use of negative pressure wound therapy in primary hip and knee arthroplasties: a randomized controlled trial |
Prof. ONG Michael Tim Yun 王添欣 |
2024.089 | Open and closed platform robotic-assisted versus conventional total knee arthroplasty: a randomised controlled trial | Prof. ONG Michael Tim Yun |
2022.252 | Double-blinded randomized controlled trial investigating the effectiveness of vitamin D supplementation in patients with end-stage knee osteoarthritis (OA) |
Prof. ONG Michael Tim Yun 王添欣 |
Page 78 of 262.